    <SEC-DOCUMENT>0001193125-23-102815-index.html : 20230417
    <SEC-HEADER>0001193125-23-102815.hdr.sgml : 20230417
    <ACCEPTANCE-DATETIME>20230417065346
    ACCESSION NUMBER:		0001193125-23-102815
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20221231
    FILED AS OF DATE:		20230417
    DATE AS OF CHANGE:		20230417
    EFFECTIVENESS DATE:		20230417

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
    		CENTRAL INDEX KEY:			0001001233
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		IRS NUMBER:				680359556
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	000-30171
    		FILM NUMBER:		23822791

    	BUSINESS ADDRESS:
    		STREET 1:		7000 MARINA BLVD
    		CITY:			BRISBANE
    		STATE:			CA
    		ZIP:			94005
    		BUSINESS PHONE:		5109706000

    	MAIL ADDRESS:
    		STREET 1:		7000 MARINA BLVD
    		CITY:			BRISBANE
    		STATE:			CA
    		ZIP:			94005

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
    		DATE OF NAME CHANGE:	20000208
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>d471891dars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: d471891dars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>